← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2016Last known activity
Mar 15, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 3 (5 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT04290572Lead sponsorPhase 3Mar 15, 2020
- NCT04290572Overall official - principal investigatorPhase 3Mar 15, 2020
- NCT03585179Lead sponsorPhase 3Aug 1, 2018
- NCT03585179Study directorPhase 3Aug 1, 2018
- NCT02823236Overall official - principal investigatorPhase 3Aug 1, 2016
- NCT02823236Lead sponsorPhase 3Aug 1, 2016
- NCT03585140Lead sponsorN/AJan 1, 2016
- NCT03585140Overall official - principal investigatorN/AJan 1, 2016
- NCT03585140Reponsible party - principal investigatorN/AJan 1, 2016
Details
- Last known activity
- Mar 15, 2020